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ABStrAct
HIV infection among people who inject drugs (PWID) in Kenya is at 18%, and has been 
attributed to risky injecting practices. The risk environment enabling these practices has 
not been explored. This paper reports findings from Access to Care, a qualitative study in 
Kenya. Using in-depth interviews with PWID, we explore how the introduction of needle 
and syringe programmes (NSP) has impacted on needle and syringe sharing. PWID report 
significant reductions in sharing injecting equipment following NSP, although sharing 
continues, linked to challenges in supply and amongst PWID living with HIV, linked to 
hopelessness for the future. We conclude that NSP should expand across Kenya, linked 
to efforts to overcome delivery challenges and efforts to support people living with HIV. 
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introDuction
HIV prevalence within the Kenyan 
population of People Who Inject Drugs 
(PWID) is an estimated 18%, three times 
that of the general population, and being 
even more burdensome among women 
who inject drugs, whose prevalence is 
estimated at 44% (NACC, 2012). Other 
countries in Sub Saharan Africa are also 
reporting injecting drug use as a major 
risk factor for HIV ( Needle et al 2006; 
Mathers et al,. 2008; HRI 2014). The shar-
ing and reuse of needles and syringes is a 
key risk factor for HIV for PWID ( Mathers 
et al,. 2008; Eluwa et al, 2012). A 2011 
study in Kenya reported high rates of 
sharing, with almost 50% of PWID sur-
96
veyed reporting sharing at their last in-
jection (CAHR, 2013). In response the Ke-
nyan government has sought to respond 
to the needs of PWID (NACC, 2009), in 
particular through partnering with civil 
society organisations to introduce a nee-
dle and syringe programme (NSP). NSP 
are evidenced to reduce HIV infections 
among PWID through providing a regular 
supply of unused needles and syringes 
(WHO, 2004). 
The Needle and Syringe programme 
in Kenya, one of the first in Sub Saharan 
Africa, was pioneered by The Kenya AIDS 
NGOs Consortium (KANCO). The pro-
gramme, focusing on Nairobi and Coast 
regions, was implemented by community 
based organisations working in harm re-
duction (Nairobi Outreach Services Trust 
in Nairobi; Muslim Education and Welfare 
Trust and Reachout Centre Trust in Mom-
basa, Teenswatch in Ukunda and The 
Omari project in Malindi). The model fol-
lowed focused on a combined fixed-site 
and outreach model of distribution. The 
programme was rolled out as a flexible 
needle and syringe exchange programme 
without a strict one-for-one policy. The 
programme end line report noted that 
88% of PWID interviewed reported us-
ing a clean needle and syringe (Mutuku, 
2014). After inception, a number of or-
ganizations also initiated NSPs, including 
Medecins du Monde (MdM) and Support 
for Addiction, Prevention and Treatment 
of Addiction (SAPTA). Combined with 
these and other programmes that came 
after, an approximate 4500 PWID had 
been reached with clean injecting equip-
ment, and over half of PWID surveyed re-
ported using sterile injecting equipment 
in the country (HRI, 2014). There are now 
efforts to scale-up the NSP programme 
across Kenya. 
There has been little study of harmful 
injecting practices, the risk environments 
for them, and how NSP programmes 
can be developed in response in African 
contexts. Previous study in Kenya high-
lighted the influence of policing on reuse 
of needles and syringes left in injecting 
sites (Beckerleg, 2005). Although avail-
ability of clean needles and syringes is a 
core factor in sharing, there can also be 
a combination of environmental, political 
and social factors that increase the risk 
of sharing (Bourgois, 1998; Rhodes, et 
al., 2005; WHO 2004; Strathdee, et al., 
2010). These factors include, but are not 
limited to, homelessness, incarceration, 
local policing practices, costs of syringes, 
drug trafficking and distribution routes, 
gender and laws and policies governing 
possession of drugs and drug parapher-
nalia (WHO,2004; Strathdee, et al., 2010). 
As the needle and syringe programme 
developed in Kenya we set out to investi-
gate PWID experiences of the programme 
and its reported impacts. In-depth study 
of the programme and responses to it is 
essential to understand how the NSP was 
implemented and shaped in these specific 
contexts and risk environments (Rhodes 
et al, 2009). Understanding these expe-
riences is key to informing the on-going 
development of NSP in Kenya and across 
Sub-Saharan Africa. 
MethoD
This paper draws on data collected 
through the Access to Care Study, a lon-
gitudinal, qualitative study, employing 
in-depth interviews and observations to 
understand PWID experiences of HIV and 
the risk environment for them. Here we 
report on data as it relates to experiences 
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of NSP in particular; elsewhere we have 
reported on experiences of drug treat-
ment and methadone (Rhodes et al., 
2015, Rhodes et al., 2015). The study was 
based in three areas in Kenya: Nairobi and 
then Malindi and Ukunda in Coast prov-
ince. We followed PWID over three waves 
of data collection to understand changes 
in experience, and increase depth of un-
derstanding of the social and structural 
context. We conducted interviews with 
109 PWID at wave 1 in late 2012 just as 
NSP was being introduced, sampling for 
a range of experiences based on gender 
(33 were female respondents), and HIV 
status (44 PWID were living with HIV). We 
repeated interviews and included others 
in our sample over two further waves in 
2013 after NSP was introduced, interview-
ing a total of 118 people who use drugs. 
These interviews explored the day-to-day 
lives of PWID in relation to their drug use 
and access to harm reduction, drug treat-
ment and HIV prevention and care ser-
vices, and recorded how these were influ-
enced by the social environment.
Analysis followed a thematic approach 
(Ezzy, 2002), iterating with on-going data 
collection to explore emerging themes. 
Interviews were recorded and tran-
scribed. We read transcripts as a group 
and identified emerging themes. We 
then explored for these themes across 
the data set. Based on these initial analy-
ses we developed a coding framework 
which we applied across the data. Initial 
findings were discussed with commu-
nity stakeholders and at an international 
conference (Ndimbii, 2013) to further 
develop and explore findings. The study 
had ethical approval from the University 
of Nairobi and the London School of Hy-
giene and Tropical Medicine. All respon-
dents provided informed consent; all 
names used are pseudonyms to protect 
confidentiality. 
reSultS
We first report how PWID described 
needle and syringe sharing to us before 
NSP was introduced. The second section 
focuses on accounts following the intro-
duction of NSP.
Needle and syringe access and sharing 
before NSP introduction
PWID commonly reported that they 
didn’t share needles and syringes as our 
study started, and before NSP was intro-
duced. This was often presented around 
an awareness of HIV and the risks that 
sharing posed: 
“I am so careful because of HIV, be-
cause I heard about it, that is why I 
don’t like to share syringes with any-
body” (Nelson)
Awareness of HIV was generally high 
across those we interviewed, linked to 
long-standing outreach work in the com-
munity. However, these reports of not 
sharing we interpret as often offering 
‘public accounts’ presented to us, reflect-
ing the shame and stigma linked to needle 
and syringe sharing. Through repeat in-
terviews we developed trust, and people 
would shift their accounts, from claims 
of having never shared, to disclosing they 
had. Beatrice, in the first account narrated 
how she had never shared, including nev-
er sharing with her husband, an injecting 
drug user as well: “I don’t even share nee-
dles with my husband” In later interview 
accounts, she did disclose her previous 
sharing, as well as disclose her recent sero 
conversion of HIV. “[Interviewer- How was 
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it until you thought of being tested (for 
HIV)?] Because me I was at times, I was 
sharing the needle with my husband”.
Accounts of managing risk of sharing 
and awareness of the risks involved were 
however widespread suggesting there 
were common efforts to avoid it. Access 
to clean injecting equipment was report-
ed to be difficult and involved a balance 
between the prevention of withdrawals, 
hustling to get drug money, navigating a 
punitive policing environment and op-
erating hours of pharmacies. Before the 
introduction of the NSP, access to clean 
injecting equipment was mainly from re-
tail pharmacies and shops in the vicinity 
of drug using sites. 
It wasn’t always possible to buy from 
chemists and access to clean injecting 
equipment was then reliant upon medical 
practitioners and veterinarians, but also 
drug dealers, ‘hit doctors’ (PWID who are 
paid to inject others) as well as friends 
and other people who inject:
“R: I went and bought a syringe from 
someone who sells up there for fif-
teen shillings per syringe… 
I: But it is not a Chemist
R: no, it is not a Chemist. At the 
Chemist they at times refuse to sell 
to us” (Lara)
Buying needles was limited by the pos-
sibilities of getting money, which itself 
required hard work and careful planning, 
and for many a combination of ‘hustling’, 
petty crime, sex work, begging, and oc-
casionally formal work, which was limited 
for most.
As well as buying new needles and 
syringes to avoid sharing, there were 
careful efforts to store and carry injecting 
equipment that had already been used 
for later reuse. Abraham for example, 
who reported never having shared, gave 
this account: 
“I: And you use the same needle for 
a week?
R: Yeah, that only one needle.
I: How blunt do they get?
R: Yeah I wash, I finish injecting, I take 
my needle, it get wash, I take the pa-
per, newspaper, I roll it, I tie it with a 
rope and I keep it in my pocket.
I: Do you have the needle now?
R: I go round with my needle.”
Whereas this carrying of needles and 
syringes for use would minimize risks 
of sharing it would increase other risks. 
Needle and syringe possession in Kenya 
is illegal, leading to risk of imprisonment, 
police violence and demands for bribes: 
“you cannot keep walking around 
with this thing…if you are caught by 
the government, there are those who 
spoil, there are those who will take you 
to the police. Now if taken to the police 
you see you will really suffer” (Simba)
PWID were therefore also afraid of car-
rying needles and syringes. In response 
people would leave needles and syringes 
hidden in walls, under rocks, or under 
rubbish in public areas, to allow them to 
have easy access when in a drug using 
site. It was however possible for others 
to find and then use this equipment that 
others had left: 
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“Maybe he is seeing where I am hid-
ing it. When he sees where I am hid-
ing it, when I leave, He comes and 
takes it. Now me when I come back I 
find it is not the one” (Ruth)
Sharing was also widely reported to us. 
As detailed above, access to clean inject-
ing equipment was reported to be dif-
ficult and involved a balance between a 
range of priorities. PWID talked of ‘strug-
gling’ to get clean injecting equipment. 
Accounts discussed reuse of friends’ 
needles and syringes, those found in in-
jecting sites, and collecting used needles 
and syringes from hospital dump sites. 
Whilst some could rely on pharmacies for 
access, others struggled, with damaging 
consequences: 
“We just share syringes because the 
chemists are not there, people refuse 
to sell them to us you see? We have 
to share the syringes, so I used to 
share the syringes with my boyfriend 
and then I just got positive in that 
way.” (Sara)
Distance to pharmacies, and their opening 
hours, were also cited as limiting factors. 
Accessing clean needles and syringes 
was also linked to the cost of purchase, 
which, although relatively low (between 
Ksh. 10 and 20, equivalent to 0.11 and 
0.2 USD) was unaffordable for many who 
struggled to address basic needs of food 
and shelter alongside their addiction:
“Now you find that we still share, 
because yes, you have got some 
money for the drug, like 250 shillings, 
the money you have is enough for 
the drugs, you have nothing for the 
injection and you do not have the 
injection… you see and you want to 
recover so you will go to a friend and 
ask him ‘bro, help me with yours I 
want to inject myself then I return it 
to you’” (Sam)
Sharing was also reported amongst 
those living with HIV, or those who as-
sumed they were HIV positive. People 
would share because they were ‘already 
sick’ and ‘did not care’:
“We usually say the only thing left for 
us is to die…” (Ruth)
For those already living with HIV shar-
ing was considered to pose no additional 
risk. There were a few people who report-
ed sharing and having been unaware of 
the risks involved:
‘I used to share those needles. You 
know I didn’t know about HIV that 
can come through that thing. So 
we used to share, we used to share’ 
(Moosa)
Others described sharing but being se-
lective about whom they shared with to 
manage HIV risk. PWID would ‘look’ to 
see whether others were HIV positive or 
not:
“I can normally tell one is okay and 
one is sick” (Solo)
Assumptions about HIV positivity 
would then shape decisions to share, for 
example, an assumption that a friend 
was HIV negative would influence a deci-
sion to share. ‘Trust’ was also associated 
with sharing, with people who considered 
other individuals as ‘okay’ – i.e. not HIV 
positive. 
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Accounts after the introduction of NSP
Following the introduction of NSP 
PWID reported gratefulness for the pro-
gram, highlighting the positive changes 
it had made in their experiences. Many 
PWID reported significant improvements 
in their access to clean injecting equip-
ment and impacts on sharing practices:
“Yes there have been changes, be-
cause now if you use one needle 
once, you use, you throw it, because 
you have many”(Susie)
There were even references to the drug 
using sites being ‘flooded’ with needles 
and syringes, and when out walking in the 
community people would show us the 
needles and syringes they were carrying. 
The NSP reached people through the 
drop in centres and outreach workers tak-
ing supplies to people in the community. 
An informal secondary exchange by PWID 
was also reported. Some of the hit doctors, 
PWID and peddlers would receive the nee-
dles and syringes from the outreach proj-
ects and distribute these further, some-
times at a small charge, sometimes in an 
effort to support the hard to reach PWID:
“Yeah, people are not sharing, be-
cause even if I go to my friend to tell 
him help me with your needles he’ll 
tell you ‘I’m not giving you my needles, 
I’ll give you this new one’. (Charo)
Despite the availability of free needles 
and syringes through the programme, 
some PWID reported still accessing nee-
dles and syringes from the pharmacies:
“I: Where are you getting them from 
at the moment? mainly from the 
pharmacy?
R: Yeah…Down there.
I: Yeah, what about from the [out-
reach] project do you get them from 
there?
R: The problem is I really, really like to 
get from them but it’s so far away…
sometimes I don’t have money to 
take a pikipiki, motorbike from here 
up to there.” (Pat)
This relative convenience of pharma-
cies, despite cost, hints at the limits on 
delivery of NSP, including the limiting 
opening hours of the outreach projects, 
the distance to them, and the difficulty 
for outreach workers of finding some 
PWID, as well as interruptions to the sup-
ply of clean needles and syringes to the 
outreach projects.
Gaps and challenges in the supply from 
the NSP were linked to accounts of con-
tinued sharing. The NSP experienced a 
number of implementation challenges 
including interrupted delivery, which 
would result in shortage of needles and 
syringes: 
“Like this week they did not bring 
for us, so if I have a syringe and I 
have maybe used it someone will 
borrow me. I tell them that I have 
used it but they still want it and I 
don’t have a new one which I can 
give them to use, but they still in-
sist that I give them the one I have 
used”(Ruth)
Outreach projects were operating 
under resource constraints, including 
sometimes in supplies of clean needles 
and syringes, with outreach workers hav-
ing a large number of people to cover, 
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which would limit the contact times be-
tween PWID and outreach workers. The 
fact that they were also not operation-
al over weekends meant delivery gaps 
which they attempted to cover for by 
providing more needles and syringes on 
Fridays. 
There were reports of continued shar-
ing following the introduction of NSP re-
lated to PWID living with HIV. As reported 
above, sharing in the context of HIV status 
was reported before NSP, and continued, 
again linked to an experience of hopeless-
ness around HIV: 
‘R And when you tell them they say 
we are already dead 
I: Right how do you mean?
R Yaani, they tell you they are already 
dead because they have already get 
HIV…so they use one needle for three 
people. (Abraham)
DiScuSSion
Based on our findings PWID in Kenya 
are reporting the introduction of NSP as 
leading to significant reductions in needle 
and syringe sharing. In support of the 
community surveys indicating reducing 
needle and syringe sharing (Mutuku et al 
2014), these findings demonstrate further 
that the programme is acceptable and 
accessible to many. These findings point 
towards an imminent and immediate 
need to scale up needle and syringe pro-
grammes in Kenya, based on the potential 
for significant impact on Kenya’s HIV epi-
demic and evidence of increased benefits 
from delivery at scale and integration 
with other areas of HIV prevention, such 
as HIV treatment and opioid substitution 
therapy (Strathdee et al 2010; Rhodes, et 
al 2015).
These qualitative findings however also 
point to specific challenges and gaps in 
access to the emerging NSP programme 
in Kenya. The limits on accessing NSP at 
weekends indicate a need to explore solu-
tions to this. Outreach projects are already 
working under considerable resource con-
straints and additional support would be 
needed to allow this. The continuing role 
of private pharmacies as an access point 
for needles and syringes is another area 
that could be developed to resolve week-
end access, and also to support overall 
reach (see WHO, 2014; APMG, 2010; 
Charapkani, Newman, Shunmugan & Du-
brow, 2013). Interruptions to the supply 
for NSP highlights the continued need for 
attention to logistical, financial and orga-
nizational contexts. There is need for con-
tinued action to foster enabling attitudes 
and policy, which would help in address-
ing these operational challenges. 
Continued sharing amongst PWID liv-
ing with HIV must also be a core target for 
intervention. That some PLHIV perceive 
themselves as already ‘dead’ indicates a 
hopelessness around HIV status that lim-
its the potential for engaging in preven-
tative measures, including NSP but also 
other areas of HIV prevention, treatment 
and care. There is an urgent need to ad-
dress the understanding and expectations 
of HIV within a context of addressing bar-
riers to integrated HIV care that includes 
NSP. 
Our findings also demonstrate the ac-
tive role for PWID in managing HIV risk 
and taking actions to manage the limits on 
access to clean needles and syringes. The 
organic development of PWID in second-
ary distribution of needles and syringes 
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is an important area for development to 
support further access. Such peer distri-
bution is demonstrated in other contexts 
in supporting access to HIV prevention 
and care (APMG, 2010). The develop-
ment of more formal peer distribution in 
Kenya, linked to the outreach led NSP pro-
gramme, could be an important avenue 
to reach more marginalized PWID. 
In conclusion, our study is one of the 
first to qualitatively explore the delivery 
of NSP in Sub-Saharan Africa and there-
fore makes a valuable contribution to 
an emerging focus for policy and pro-
grammes. We have shown how PWID 
report the introduction of NSP leading 
to significant reductions in the sharing of 
injecting equipment, supported by other 
factors such as outreach and continued 
pharmacy access. Continued sharing is 
however a challenge and scale-up of NSP 
in Kenya, with specific attention to opera-
tional challenges, the needs of PLHIV, and 
exploring the role of peer distribution will 
be essential to confronting the HIV epi-
demic amongst PLHIV.
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